Sensing danger: toll-like receptors and outcome in allogeneic hematopoietic stem cell transplantation

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Bone Marrow Transplantation

• Publication date

  2017-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/bmt.2016.263PMID 27941769
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gut microbiome derived metabolites modulate intestinal epithelial cell damage and mitigate Graft-versus-Host Disease

  2016cited by this paper
• Recent progress in the development of Toll-like receptor (TLR) antagonists

  2016cited by this paper
• A sentinel goblet cell guards the colonic crypt by triggering Nlrp6-dependent Muc2 secretion

  2016cited by this paper
• Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice

  2016cited by this paper
• Sensing Gram-negative bacteria: a phylogenetic perspective.

  2016cited by this paper
• Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease.

  2015cited by this paper
• Impaired T Cell Responsiveness to Interleukin-6 in Hematological Patients with Invasive Aspergillosis

  2015cited by this paper
• Toll-like receptor polymorphisms in allogeneic hematopoietic cell transplantation.

  2015cited by this paper
• The Role of Microbiota on the Gut Immunology.

  2015cited by this paper
• Control of adaptive immunity by the innate immune system

  2015cited by this paper
• Differential Effect of MyD88 Signal in Donor T Cells on Graft-versus-Leukemia Effect and Graft-versus-Host Disease after Experimental Allogeneic Stem Cell Transplantation

  2015cited by this paper
• Donor Nucleotide-Binding Oligomerization-Containing Protein 2 (NOD2) Single Nucleotide Polymorphism 13 Is Associated with Septic Shock after Allogeneic Stem Cell Transplantation.

  2015cited by this paper
• Host–microbe cross talk in cancer therapy

  2015cited by this paper
• Chemotherapy‐driven dysbiosis in the intestinal microbiome

  2015cited by this paper
• Mucositis: pathobiology and management

  2015cited by this paper
• TLR Signaling Modulates Side Effects of Anticancer Therapy in the Small Intestine

  2015cited by this paper
• Associations between gastrointestinal toxicity, micro RNA and cytokine production in patients undergoing myeloablative allogeneic stem cell transplantation.

  2015cited by this paper
• The Role of Pattern-Recognition Receptors in Graft-Versus-Host Disease and Graft-Versus-Leukemia after Allogeneic Stem Cell Transplantation

  2014cited by this paper
• Impaired interferon-alpha production by plasmacytoid dendritic cells after cord blood transplantation in children: implication for post-transplantation toll-like receptor ligand-based immunotherapy.

  2014cited by this paper
• Pretransplant C‐reactive Protein as A Prognostic Marker in Allogeneic Stem Cell Transplantation

  2014cited by this paper
• Prevention of graft-versus-host disease by adoptive T regulatory therapy is associated with active repression of peripheral blood Toll-like receptor 5 mRNA expression.

  2014cited by this paper
• The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation.

  2014cited by this paper
• Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal graft-versus-host disease.

  2014cited by this paper
• 16S rRNA Gene Pyrosequencing Reveals Shift in Patient Faecal Microbiota During High-Dose Chemotherapy as Conditioning Regimen for Bone Marrow Transplantation

  2014cited by this paper
• Systematic review: the role of the gut microbiota in chemotherapy‐ or radiation‐induced gastrointestinal mucositis – current evidence and potential clinical applications

  2014cited by this paper
• Antimicrobial-resistant Gram-negative bacteria in febrile neutropenic patients with cancer: current epidemiology and clinical impact

  2014cited by this paper
• Immunomodulation by Gut Microbiota: Role of Toll-Like Receptor Expressed by T Cells

  2014cited by this paper
• Donor TLR9 gene tagSNPs influence susceptibility to aGVHD and CMV reactivation in the allo-HSCT setting without polymorphisms in the TLR4 and NOD2 genes

  2014cited by this paper
• Profile of toll-like receptors on peripheral blood cells in relation to acute graft-versus-host disease after allogeneic stem cell transplantation.

  2013cited by this paper
• Increased susceptibility for aspergillosis and post‐transplant immune deficiency in patients with gene variants of TLR4 after stem cell transplantation

  2013cited by this paper
• Biomarkers of chemotherapy-induced diarrhoea: a clinical study of intestinal microbiome alterations, inflammation and circulating matrix metalloproteinases

  2013cited by this paper
• Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infection: Results from a Field Test of a New National Healthcare Safety Network Definition

  2013cited by this paper
• Toll‐Like Receptor Gene Polymorphisms Confer Susceptibility to Graft‐Versus‐Host Disease in Allogenic Hematopoietic Stem Cell Transplantation

  2012cited by this paper
• Sensing and reacting to microbes through the inflammasomes

  2012cited by this paper
• Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation

  2012cited by this paper
• Toll-like 4 receptor variant, Asp299Gly, and reduced risk of hemorrhagic cystitis after hematopoietic stem cell transplantation.

  2012cited by this paper
• [Prophylactic effect of TLR5 agonist flagellin on acute graft versus host disease after allogeneic hematopoietic stem cell transplantation and its mechanism].

  2012cited by this paper
• A TLR5 Agonist Enhances CD8+ T Cell-Mediated Graft-versus-Tumor Effect without Exacerbating Graft-versus-Host Disease

  2012cited by this paper
• Severity of doxorubicin‐induced small intestinal mucositis is regulated by the TLR‐2 and TLR‐9 pathways

  2012cited by this paper
• A TLR5 Agonist Enhances CD8 T Cell-Mediated Graft- versus-Tumor Effect without Exacerbating Graft-versus-Host Disease

  2012cited by this paper
• Flagellin, a TLR5 Agonist, Reduces Graft-versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplantation Recipients While Enhancing Antiviral Immunity

  2011cited by this paper
• Flagellin, a TLR5 Agonist, Reduces Graft-versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplantation Recipients While Enhancing Antiviral Immunity

  2011cited by this paper
• Influence of Polymorphisms in Innate Immunity Genes on Susceptibility to Invasive Aspergillosis after Stem Cell Transplantation

  2011cited by this paper
• Toll-like receptor 9, NOD2 and IL23R gene polymorphisms influenced outcome in AML patients transplanted from HLA-identical sibling donors

  2011cited by this paper
• Effective posttransplant antitumor immunity is associated with TLR-stimulating nucleic acid-immunoglobulin complexes in humans.

  2011cited by this paper
• Targeting HMGB1 in inflammation.

  2010cited by this paper
• Early elevation of C-reactive protein correlates with severe infection and nonrelapse mortality in children undergoing allogeneic stem cell transplantation.

  2010cited by this paper
• The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors

  2010cited by this paper
• The Role of Intestinal Microbiota in the Development and Severity of Chemotherapy-Induced Mucositis

  2010cited by this paper
• Association of HMGB1 polymorphisms with outcome after allogeneic hematopoietic cell transplantation.

  2009cited by this paper
• Graft-versus-host disease.

  2009cited by this paper
• Long-term protection from syngeneic acute lymphoblastic leukemia by CpG ODN-mediated stimulation of innate and adaptive immune responses.

  2009cited by this paper
• Toll-like receptor 4 polymorphisms and risk of gram-negative bacteremia after allogeneic stem cell transplantation. A prospective pilot study.

  2009cited by this paper
• Improved outcome of hematopoietic SCT in patients with homozygous gene variant of Toll-like receptor 9

  2009cited by this paper
• Polymorphisms in Toll-like receptor genes and susceptibility to infections in allogeneic stem cell transplantation.

  2009cited by this paper
• Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation.

  2008cited by this paper
• Regulation of humoral and cellular gut immunity by lamina propria dendritic cells expressing Toll-like receptor 5

  2008cited by this paper
• Graft-versus-host disease

  2007cited by this paper
• Mutations in Innate Immune System NOD2/CARD 15 and TLR-4 (Thr399Ile) Genes Influence the Risk for Severe Acute Graft-versus-Host Disease in Patients Who Underwent an Allogeneic Transplantation

  2006cited by this paper
• Pathogen recognition and innate immunity.

  2006cited by this paper
• Prevention of infection and graft-versus-host disease by suppression of intestinal microflora in children treated with allogeneic bone marrow transplantation

  2005cited by this paper
• Obesity alters gut microbial ecology.

  2005cited by this paper
• TLR1 and TLR6 Polymorphisms Are Associated with Susceptibility to Invasive Aspergillosis after Allogeneic Stem Cell Transplantation

  2005cited by this paper
• The pathobiology of mucositis

  2004cited by this paper
• Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantation.

  2004cited by this paper
• Oral and intestinal mucositis — causes and possible treatments

  2003cited by this paper
• Lipopolysaccharides Indirectly Stimulate Apoptosis and Global Induction of Apoptotic Genes in Fibroblasts*

  2003cited by this paper
• Insertional Inactivation of pac and rmlB Genes Reduces the Release of Tumor Necrosis Factor Alpha, Interleukin-6, and Interleukin-8 Induced by Streptococcus mutans in Monocytic, Dental Pulp, and Periodontal Ligament Cells

  2003cited by this paper
• Association of TLR4 mutations and the risk for acute GVHD after HLA-matched-sibling hematopoietic stem cell transplantation.

  2001cited by this paper
• Synthetic unmethylated cytosine-phosphate-guanosine oligodeoxynucleotides are potent stimulators of antileukemia responses in naive and bone marrow transplant recipients.

  2001cited by this paper
• Influence of protective isolation on outcome of allogeneic bone marrow transplantation for leukemia

  1998cited by this paper
• Evidence that sustained growth suppression of intestinal anaerobic bacteria reduces the risk of acute graft-versus-host disease after sibling marrow transplantation.

  1992cited by this paper
• Mitigation of secondary disease of allogeneic mouse radiation chimeras by modification of the intestinal microflora.

  1974cited by this paper

• Semaglutide treatment for PRevention Of Toxicity in high-dosE Chemotherapy with autologous haematopoietic stem-cell Transplantation (PROTECT): study protocol for a randomised, double-blind, placebo-controlled, investigator-initiated study

  2024cites this paper
• Upregulation of Insulin-like Growth Factor-I in Response to Chemotherapy in Children with Acute Lymphoblastic Leukemia

  2024cites this paper
• Broadening Horizons: Exploring mtDAMPs as a Mechanism and Potential Intervention Target in Cardiovascular Diseases

  2023cites this paper
• Thymic stromal lymphopoietin levels after allogeneic hematopoietic stem cell transplantation

  2022cites this paper
• Endothelial Dysfunction after Hematopoietic Stem Cell Transplantation: A Review Based on Physiopathology

  2022cites this paper
• Toll-like Receptor 4, Osteoblasts and Leukemogenesis; the Lesson from Acute Myeloid Leukemia

  2022cites this paper
• Is It Possible to Separate the Graft-Versus-Leukemia (GVL) Effect Against B Cell Acute Lymphoblastic Leukemia From Graft-Versus-Host Disease (GVHD) After Hematopoietic Cell Transplant?

  2022cites this paper
• Role of endothelial cells in graft-versus-host disease

  2022cites this paper
• Citrulline as a biomarker of bacteraemia during induction treatment for childhood acute lymphoblastic leukaemia

  2020cites this paper
• Gastrointestinal toxicity during induction treatment for childhood acute lymphoblastic leukemia: the impact of the gut microbiota.

  2020cites this paper
• Purine Nucleoside Phosphorylase Inhibitors as Novel Immuno-Oncology Agent and Vaccine Adjuvant

  2020cites this paper
• Insulin-Like Growth Factor Gene Polymorphisms Predict Clinical Course in Allogeneic Hematopoietic Stem Cell Transplantation

  2020cites this paper
• Therapeutic Targeting of Signaling Pathways Related to Cancer Stemness

  2020cites this paper
• Insulin-like growth factor-I predicts sinusoidal obstruction syndrome following pediatric hematopoietic stem cell transplantation

  2020cites this paper
• Morphine consumption is associated with systemic inflammation in children undergoing allogeneic hematopoietic stem cell transplantation

  2019cites this paper
• Glucagon-Like Peptide-1 Is a Marker of Systemic Inflammation in Patients Treated with High-Dose Chemotherapy and Autologous Stem Cell Transplantation.

  2019cites this paper
• Toll-Like Receptor Stimulation by MicroRNAs in Acute Graft-vs.-Host Disease

  2018cites this paper
• Targeting Toll-Like Receptors for Cancer Therapy

  2018cites this paper
• Blocking TIR Domain Interactions in TLR9 Signaling

  2018cites this paper
• Non-infectious chemotherapy-associated acute toxicities during childhood acute lymphoblastic leukemia therapy

  2017cites this paper